SignalRx Pharmaceuticals

Omaha, United States

SignalRx is a clinical-stage company that focuses on the development of effective anticancer treatments inducing the immune system.

$250K raised

Apr 2023

Undisclosed

Biotechnology Health Care Medical Oncology

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about SignalRx Pharmaceuticals

How much funding has SignalRx Pharmaceuticals raised?

SignalRx Pharmaceuticals has raised $250K in total funding. The most recent round was Undisclosed. The last funding was announced in April 2023.

Where is SignalRx Pharmaceuticals headquartered?

SignalRx Pharmaceuticals is headquartered in Omaha, United States.

What does SignalRx Pharmaceuticals do?

SignalRx is a clinical-stage company that focuses on the development of effective anticancer treatments inducing the immune system.

What stage is SignalRx Pharmaceuticals at?

SignalRx Pharmaceuticals is at the Undisclosed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 26, 2023.

MLA

"SignalRx Pharmaceuticals — Funding & Investors." VCBacked, April 26, 2023, https://www.vcbacked.co/company/signalrx-pharmaceuticals. Accessed July 2, 2026.

APA

VCBacked. (2023). SignalRx Pharmaceuticals — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/signalrx-pharmaceuticals

Wikipedia (cite web)

{{cite web |title=SignalRx Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/signalrx-pharmaceuticals |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 26, 2023.